CAPN1 and neoplasm: Overall, the activity of calpain-1 and calpain-2, the two ubiquitous calpains, could be impaired by targeted treatment to impede cell transformation, suppress the enhanced motility, adhesion disassembly and the cell cycle progression, and by inducing tumor cell death.